Drug Shortage Report for AVAPRO

Last updated on 2021-02-16 History
Report ID 134199
Drug Identification Number 02237923
Brand name AVAPRO
Common or Proper name Avapro
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 75MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 90
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-03-24
Actual start date
Estimated end date 2021-06-30
Actual end date
Shortage status Anticipated shortage
Updated date 2021-02-16
Company comments Delay in production The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-02-16 French Compare
v1 2021-02-16 English Compare